CTOs on the Move

Glaukos

www.glaukos.com

 
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.glaukos.com
  • 229 Avenida Fabricante
    San Clemente, CA USA 92672
  • Phone: 949.481.0510

Executives

Name Title Contact Details

Similar Companies

OBP Medical Inc.

OBP Medical Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

American Biocare

American Biocare is a Troy, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OXiGENE

OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.

Genesis Medical Imaging

Genesis Medical Imaging is a Huntley, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lifewave

Lifewave is a North Highlands, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.